{"text_format":"2","workbook":"xls","n_sheets":1,"sheets":["Supplementary Table S1"],"not_rendered":{"charts":0,"images":0,"macros":0,"external_links":1,"defined_names":0,"comments":0,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"run_cost":"one","rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"Supplementary Table S1","index":0,"n_rows":25,"n_cols":6,"rows_kept":25,"cut":false,"hidden":false,"merged":[[3,1,4,1],[3,6,3,7],[3,2,3,3],[3,0,4,0],[3,4,4,4],[3,5,4,5],[5,0,5,5],[14,0,14,5],[20,0,20,5],[23,0,23,5]],"flags":["formulas_cached_only"]}
["Supplementary Material (ESI) for Molecular BioSystems"]
["This journal is (c) The Royal Society of Chemistry, 2011"]
[]
["Spot no.","Protein name","Intensity by SYPRO Ruby dye (Mean ± SEM)",null,"Ratio (COD/ Control)","p values"]
[null,null,"Control","COD-treated"]
["Glycoproteins whose levels of glycoforms were significantly increased in COD-treated MDCK cells"]
[393,"Elongation factor 2 (EF-2)","0.1452 ± 0.0394","0.1294 ± 0.0174",0.8910073624368312,0.7227625381766571]
[423,"Cytokeratin type II","0.0740 ± 0.0163","0.0483 ± 0.0040",0.6521179144941522,0.16259702332006454]
[890,"Macrophage scavenger receptor type I","0.0502 ± 0.0094","0.0353 ± 0.0264",0.7026578602218442,0.6088855681525605]
[961,"Translocase of outer mitochondrial membrane 40 homolog isoform 2","0.1064 ± 0.0180","0.1108 ± 0.0200",1.0419326106474844,0.8721307549769961]
[967,"PIBF1 protein","0.1548 ± 0.0179","0.2176 ± 0.0361",1.4058832424133156,0.15721493606955494]
[1042,"Isocitrate dehydrogenase 3 (NAD+) alpha isoform 2","0.0809 ± 0.0220","0.0828 ± 0.0061",1.0235098028989107,0.9357157566499645]
[1045,"Protein phosphatase 1, catalytic subunit, alpha","0.0700 ± 0.0216","0.0682 ± 0.0074",0.9738647821827146,0.938207438364637]
[1378,"Proteasome subunit beta type 3 (Proteasome theta chain) (Proteasome chain 13) (Proteasome component C10-II)","0.1376 ± 0.0209","0.1690 ± 0.0266",1.2284798762465128,0.38076295916056446]
["Glycoproteins whose levels of glycoforms were significantly decreased in COD-treated MDCK cells"]
[625,"Heterogeneous nuclear ribonucleoprotein K","0.1464 ± 0.0122","0.1603 ± 0.0064",1.0945053864341356,0.34394638308426495]
[828,"Alpha enolase (2-phospho-D-glycerate hydro-lyase) (Non-neural enolase) (NNE) (Enolase 1) (Phosphopyruvate hydratase) (C-myc promoter-binding protein) (MBP-1) (MPB-1) (Plasminogen-binding protein) isoform 1","0.4020 ± 0.0376","0.3401 ± 0.0208",0.8461268264335835,0.18801196428701472]
[837,"ARP3 actin-related protein 3 homolog","0.0772 ± 0.0097","0.0937 ± 0.0089",1.2143778983883466,0.24419295483768522]
[1059,"Annexin A1 (Annexin I) (Lipocortin I) (Calpactin II) (Chromobindin 9) (P35) (Phospholipase A2 inhibitory protein)","0.5013 ± 0.0466","0.4423 ± 0.0410",0.882246419453819,0.36954771505878503]
[1118,"Heterogeneous nuclear ribonucleoprotein A2/B1 isoform 2","0.2736 ± 0.0653","0.4330 ± 0.0729",1.5822916504506106,0.1420661398245806]
["Glycoproteins whose glycoforms were present only in COD-treated MDCK cells"]
[1134,"Proteasome (prosome, macropain) 26S subunit, non-ATPase, 14 isoform 2","0.0713 ± 0.0071","0.0961 ± 0.0094",1.3486124130653208,0.06703687181987464]
[1387,"Proteasome (prosome, macropain) subunit, beta type, 3 isoform 1","0.1227 ± 0.0158","0.1043 ± 0.0114",0.8494916329197445,0.3701426297837149]
["Glycoproteins whose glycoforms were absent in COD-treated MDCK cells"]
[1139,"Annexin A2","0.1428 ± 0.0498","0.1331 ± 0.0471",0.9318407379829686,0.8906168534561187]